pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,477 catalysts · 5,159 phase readout · 2,327 8k filing · 316 pdufa · 275 earnings · 108 phase 2 completion · 50 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 32 catalysts2026-07-30: 13 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: approval×type: pdufa×clear all
type
  • phase readout5,159
  • 8k filing2,327
  • pdufa316
  • earnings275
  • phase 2 completion108
  • phase 1 completion50
phase 1 2 completion
28
  • phase 1 initiation22
  • phase 0 trial completion21
  • phase 1 2 initiation9
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05139004: 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome

    Sponsor: City of Hope Medical Center. Phase: PHASE1. Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07383584: The Impact of Extending Sleep Before Joint-replacement Surgery on Post-surgical Pain

    Sponsor: Defense and Veterans Center for Integrative Pain Management. Phase: NA. Conditions: Joint (Knee or Hip Replacement)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07698184: The Condition of the Temporomandibular Joint in Hemiplegia

    Sponsor: Ayşe Ukbe Baykut. Phase: . Conditions: Hemiplegia, Temporomandibular Disorder (TMD)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT00009633: Follow-up Visit of High Risk Infants

    Sponsor: NICHD Neonatal Research Network. Phase: . Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07664033: AI-based Model for Rehabilitation Engagement and Motor Performance Evaluation in Pediatric Patients: A Pilot Study

    Sponsor: IRCCS Eugenio Medea. Phase: NA. Conditions: Neuromotor Impairments

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03489733: Prevention of Allergic Diseases in Infants

    Sponsor: HiPP GmbH & Co. Vertrieb KG. Phase: NA. Conditions: Atopic Diseases

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT05967533: The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors

    Sponsor: University of California, Davis. Phase: PHASE1. Conditions: Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Neoplasm, Advanced Melanoma, Advanced Renal Cell Carcinoma, Advanced Triple-Negative Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer (AJCC) v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Stage III Colorectal Cancer AJCC v8, Stage III Lung Cancer AJCC v8, Stage III Renal Cell Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06508333: Efficacy and Safety of Vitamin D Supplementation Combined With Alarm Therapy in Treating Nocturnal Enuresis

    Sponsor: Xing Liu. Phase: NA. Conditions: Enuresis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05863052: Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

    Sponsor: University of Oklahoma. Phase: . Conditions: Immune Checkpoint Inhibitors, Metastatic Solid Tumor, Nonsmall Cell Lung Cancer, Melanoma, Renal Cell Carcinoma, Gastrointestinal Cancer, Squamous Cell Carcinoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04529252: Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases

    Sponsor: Mayo Clinic. Phase: . Conditions: Spinocerebellar Ataxias, Cerebellar Ataxia, Nucleotide Repeat Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04544852: Uncovering and Overcoming the Barriers of Colorectal Cancer Screening Amongst Spouses of Patients With Colorectal Cancer

    Sponsor: National University Health System, Singapore. Phase: NA. Conditions: Colorectal Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03997552: NIPSA Versus Marginal Approach by Palatal Incision and MIST in Periodontal Regeneration

    Sponsor: Universidad de Murcia. Phase: NA. Conditions: Periodontitis, Periodontal Diseases, Periodontal Pocket

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07689188: Safety and Efficacy of Roflumilast Foam 0.3% in Adolescent and Adult Subjects With Hidradenitis Suppurativa

    Sponsor: Harrison Dermatology. Phase: PHASE2. Conditions: Hidradenitis Suppurativa (HS)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06408103: Efficacy of a Multicomponent Intervention on Cognitive Function for the Caregiver-patient Dyad

    Sponsor: Universidad de Santander. Phase: NA. Conditions: Mild Cognitive Impairment

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07524803: Lung Cancer Screening for Early Detection of Suspicious Lung Nodules in Latin America(LUCAS-LATAM)

    Sponsor: Latin American Consortium for the Lung Cancer Research. Phase: . Conditions: Lung Cancer Screening

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06280703: A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)

    Sponsor: Eli Lilly and Company. Phase: PHASE1. Conditions: Healthy, Type 1 Diabetes Mellitus

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07352527: New Clinical Decision Support Score Based on Steroid Hormone Profiling in the Diagnosis of MACS

    Sponsor: University Hospital, Bordeaux. Phase: . Conditions: Endocrine Disease

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT05870527: Pupillary Dilation During Post-Auricular Vagal Nerve Stimulation

    Sponsor: NYU Langone Health. Phase: NA. Conditions: Hearing Loss

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06491927: Long Term Follow-up for RGX-202

    Sponsor: REGENXBIO Inc.. Phase: . Conditions: Duchenne Muscular Dystrophy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07336017: Impact on Postpartum Anal Incontinence of an Educational Program for Delivery Room Staff

    Sponsor: University Hospital, Strasbourg, France. Phase: . Conditions: Anal Incontinence

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05883540: Lysergic Acid Diethylamide (LSD) in Palliative Care

    Sponsor: University Hospital, Basel, Switzerland. Phase: PHASE2. Conditions: Palliative Care, Pain, Anxiety, Depression, Demoralization, Psychological Distress, Quality of Life, Caregiver Burden, Fear of Death, Existential Distress

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05265689: Study to Improve Adolescent Bicycling Safety

    Sponsor: Cara J. Hamann. Phase: NA. Conditions: Bicycling, Knowledge, Adolescent, Self Efficacy, Education, Attitudes, Practice, Safety, Behavior

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07499089: Together-Breast Cancer Support Platform

    Sponsor: Cedars-Sinai Medical Center. Phase: . Conditions: Breast Cancer, Breast Cancer Survivors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07396350: IMMEDIATE IMPLANT With Different Types of Membrane

    Sponsor: Mansoura University. Phase: NA. Conditions: Tooth Extraction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07416591: Role of Saline Infusion Sonohysterography in Detection of Pelvic Adhesions in Infertile Women

    Sponsor: Sohag University. Phase: NA. Conditions: Infertile Women With Pelvic Adhesions

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07031791: PETRA: Pictorial Assessment of Task Occurrence and Upper Limb Avoidance Behaviors

    Sponsor: University Hospital, Angers. Phase: . Conditions: Thoraco-brachial Outlet Syndrome, ADAP-shoulder Scale, PETRA

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07325591: Efficacy and Safety of Tazbentetol in ALS Participants

    Sponsor: Spinogenix. Phase: PHASE2. Conditions: Amyotrophic Lateral Sclerosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07556874: Descriptive Analysis of Surgeries in Patients With Multiple Osteochondromas

    Sponsor: Istituto Ortopedico Rizzoli. Phase: . Conditions: Multiple Osteochondroma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07494318: Advanced GastroInstestinal(GI) Surgery Training in Residency and Fellowship.

    Sponsor: Methodist Health System. Phase: . Conditions: Gastro-Intestinal Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03108118: Diaphragm Injury and Dysfunction During Mechanical Ventilation

    Sponsor: University Health Network, Toronto. Phase: . Conditions: Respiratory Insufficiency, Diaphragm Injury, Mechanical Ventilation Complication

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07334197: Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy

    Sponsor: Tanta University. Phase: NA. Conditions: Ppm, Cardiomyopathy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06567860: Characterizing Late-season Influenza Vaccine Responses to Compare the 2023 and 2024 Vaccine Formulations

    Sponsor: La Jolla Institute for Immunology. Phase: PHASE4. Conditions: Influenza A

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07396220: Psychotherapy Combined With Intranasal Esketamine for the Treatment of Suicidal Ideation

    Sponsor: University of California, San Diego. Phase: NA. Conditions: Suicidal Ideation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06617182: Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.

    Sponsor: Yongquan Shi. Phase: PHASE2. Conditions: Radiation Enteritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07484724: A Study Evaluating the Safety and Efficacy of JS212 Combination Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma

    Sponsor: Shanghai Junshi Bioscience Co., Ltd.. Phase: PHASE2. Conditions: Advanced Esophageal Squamous Cell Carcinoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06628323: Neuro-VR: Augmenting a Virtual Reality-based Therapy With Biofeedback for Auditory Hallucinations

    Sponsor: University Hospital Bispebjerg and Frederiksberg. Phase: NA. Conditions: Auditory Hallucinations, Schizophrenia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07598123: Effects of Multi-component Exercise on Physical Performance and Sleep Quality in Older Adults

    Sponsor: Tunghai University. Phase: NA. Conditions: Aging, Sleep Quality, Physical Performance

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06692959: A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer

    Sponsor: University of Southampton. Phase: PHASE2. Conditions: Colorectal Cancer

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT02893059: Evaluation of a Data Collection Tool in Clinical Research: Comparison Between the Data Collected by Patient Diary and Data From Medical Administrative Databases

    Sponsor: Centre Hospitalier Universitaire de Nīmes. Phase: . Conditions: Case Report Form, Declaration Bias, Health Insurance Database

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04027296: Development and Validation of the GLORI-COPD Score

    Sponsor: University of Paris 5 - Rene Descartes. Phase: . Conditions: Pulmonary Disease, Chronic Obstructive

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05327296: Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU2)

    Sponsor: Sedana Medical. Phase: PHASE3. Conditions: Sedation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07504796: ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

    Sponsor: NYU Langone Health. Phase: PHASE4. Conditions: Metastatic Melanoma, Advanced Melanoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05710679: Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer

    Sponsor: Centre Jean Perrin. Phase: NA. Conditions: Locally Advanced Head and Neck Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06274879: Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer

    Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: PHASE2. Conditions: Bile Duct Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06133062: Atezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular Carcinoma

    Sponsor: Chang Gung Memorial Hospital. Phase: PHASE2. Conditions: Hepatocellular Carcinoma Non-resectable

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07351227: Pediatric Airway: Noninferiority Trial of Devices for Intubation Assessment

    Sponsor: University of Sao Paulo General Hospital. Phase: NA. Conditions: Intubation, Intratracheal, Airway Management, Video Laryngoscope, Cost Effectiveness

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07476703: Expanded Studies on the SCAPIS Stockholm Reexamination Cohort

    Sponsor: Danderyd Hospital. Phase: . Conditions: Coronary Artery Disease, Arterial Stiffness, Blood Pressure, AORTIC VALVE DISEASES, Mitral Valve Stenosis and/or Insufficiency, Heart Failure, Pulmonary Disease, Chronic Obstructive (COPD), Steatohepatitis, Inflammation Biomarkers, Lipid Profile, Oral Microbiota, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Associated-dysfunction Steatohepatitis (MASH)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06204003: Cannabinoids for Pain Management and Neuroprotection From Concussion

    Sponsor: University of Regina. Phase: PHASE1. Conditions: Healthy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04816227: Expression Profile Study of Macrophages From Patients Affected by ALS or Other Related Motor Impairments

    Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: . Conditions: Amyotrophic Lateral Sclerosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05553327: Impact of a Multimodal Prehabilitation Program Before Robotic-assisted Radical Prostatectomy.

    Sponsor: Hospital Clinic of Barcelona. Phase: NA. Conditions: Prostate Cancer, Radical Prostatectomy

    full page →ctgov ↗
    ← prev
    page 93 of 110
    next →